Thomas W Schoenfeld

Title: Thomas W. Schoenfeld: Innovator in Viral Polymerases and Cloning Technologies

Introduction

Thomas W. Schoenfeld is a notable inventor based in Madison, WI (US). He has made significant contributions to the field of biotechnology, particularly in the development of viral polymerases and cloning methods. With a total of 2 patents, his work has advanced the capabilities of molecular biology.

Latest Patents

Schoenfeld's latest patents include innovations in thermostable viral polymerases and methods of use. These polymerases exhibit a combination of activities, including proofreading exonuclease activity, nick translating nuclease activity, synthetic primer-initiated polymerase activity, and reverse transcriptase activity. Additionally, he has developed compositions that include these polymerases, polynucleotides encoding them, and methods for their application. Another significant patent involves vector preparations and cloning constructs suitable for cloning DNA. These vector preparations are designed to facilitate the cloning process by utilizing double-stranded DNA molecules with specific overhangs that can hybridize with target polynucleotide sequences.

Career Highlights

Schoenfeld is currently associated with Lucigen Corporation, where he continues to innovate in the field of biotechnology. His work has been instrumental in enhancing the efficiency and effectiveness of molecular cloning techniques.

Collaborations

Throughout his career, Schoenfeld has collaborated with notable colleagues, including David Mead and Ronald Godiska. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Thomas W. Schoenfeld's contributions to biotechnology through his patents in viral polymerases and cloning methods highlight his role as a key innovator in the field. His work continues to influence molecular biology and its applications in various scientific domains.